Juvenile myelomonocytic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Juvenile myelomonocytic leukemia (JMML) is a serious chronic leukemia (cancer of the blood) that affects children mostly aged 4 and under. The average age of patients at diagnosis is 2 years old. The World Health Organization has included JMML in the category of Myelodysplastic and Myeloproliferative disorders.^[1] The name JMML now encompasses all diagnoses formerly referred to as Juvenile Chronic Myeloid Leukemia (JCML), Chronic Myelomonocytic Leukemia of Infancy, and Infantile Monosomy 7 Syndrome.

References

↑ “Myelodysplastic/Myeloproliferative Diseases Treatment – National Cancer Institute”.

fi:Juveniili myelomonosyyttileukemia

Template:WikiDoc Sources

[urlMyelodysplastic/Myeloproliferative_Diseases_Treatment_-_National_Cancer_Institute-1] “Myelodysplastic/Myeloproliferative Diseases Treatment – National Cancer Institute”.

[1]